US88331L1089 - Common Stock
Looking back on personal care stocks’ Q2 earnings, we examine this quarter’s best and worst performers, including BeautyHealth (NASDAQ:SKIN) and its peers.
We have all of the biggest pre-market stock movers that traders need to know about on Friday with the latest news breakdowns!
SKIN stock results show that Beauty Health missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024.
Skincare company BeautyHealth (NASDAQ:SKIN) missed analysts' expectations in Q2 CY2024, with revenue down 22.9% year on year to $90.6 million. Next quarter's revenue guidance of $75 million also underwhelmed, coming in 25.3% below analysts' estimates. It made a GAAP loss of $0.10 per share, down from its profit of $0.03 per share in the same quarter last year.
The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current business environment. Let’s take a look at how BeautyHealth (NASDAQ:SKIN) and the rest of the personal care stocks fared in Q1.
SKIN stock results show that Beauty Health beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024.
InvestorPlace - Stock Market News, Stock Advice & Trading Tips Beauty Health (NASDAQ:SKIN) just reported results for the first quarter of 2024...